ROSEWELL
Live / Applied — Statement of use — processing complete, to examiner (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 17 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98654038
- Mark type
- Stylized text
- Filed
- 17 Jul 2024
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Nathaniel A. Wickliffe
Goods and services
- Class 005 — Pharmaceuticals: Antihistamines; Allergy medications; Allergy relief medication; Antiallergic medicines; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for treating allergies
Owner
- RoseWell Pharmaceuticals LLC, San Diego, CA, US
- RoseWell Pharmaceuticals LLC, San Diego, CA, US
Prosecution history
- 02 Apr 2026 — ASSIGNED TO EXAMINER
- 24 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Aug 2025 — USE AMENDMENT FILED
- 24 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2025 — ASSIGNED TO EXAMINER
- 06 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Jul 2024 — NEW APPLICATION ENTERED